<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>272835</rcn>
  <id>101190878</id>
  <acronym>EMINENCE</acronym>
  <teaser>Onchocerciasis is a neglected tropical disease leading to blindness and associated with epilepsy. Most cases are in sub-Saharan Africa. The WHO has proposed that its transmission be interrupted in a third of endemic countries by 2030. The main strategy is annual...</teaser>
  <objective>Onchocerciasis is a neglected tropical disease leading to blindness and associated with epilepsy. Most cases are in sub-Saharan Africa. The WHO has proposed that its transmission be interrupted in a third of endemic countries by 2030. The main strategy is annual Community-Directed Treatment with Ivermectin (CDTI). Despite nearly 3 decades of CDTI, transmission persists in several foci. In Phase II &amp; III clinical trials, moxidectin has shown superior efficacy compared to ivermectin, clearing Onchocerca volvulus microfilariae for nearly a year. No large-scale community trials have yet been undertaken to document its effectiveness and safety for mass treatment. A barrier to onchocerciasis elimination is its co-endemicity with loiasis in Central Africa. Individuals with high Loa loa microfilaraemia may develop serious adverse events if treated with ivermectin. EMINENCE will address these challenges through: 1) a Phase IIIb community trial of annual or biannual moxidectin compared to annual ivermectin in Bafia and Monatele, Cameroon, renowned for their high transmission intensity, 2) a Phase II adaptive trial of ascending moxidectin doses on increasing L. loa microfilarial densities, and 3) a social sciences study to assess the acceptability of and adherence to moxidectin. We will evaluate and model the epidemiological impact of annual or biannual moxidectin compared to annual ivermectin through parasitological, serological and entomological surveys, and will attempt to elucidate potential differences between the two drugs regarding their effects on adult worms. We will evaluate the safety, tolerability and efficacy of moxidectin compared to ivermectin in L. loa-infected individuals in the Republic of Congo and Cameroon. Our project will contribute to the evidence-base that moxidectin may be effective and cost-effective to accelerate onchocerciasis elimination in areas where ivermectin has proved insufficient, and will investigate its safety in loiasis co-endemic areas.</objective>
  <title>Eliminating onchocerciasis with Moxidectin in endemic hotspots of Central Africa</title>
  <totalCost>5205730.25</totalCost>
  <ecMaxContribution>4986011.25</ecMaxContribution>
  <startDate>2025-06-01</startDate>
  <endDate>2030-05-31</endDate>
  <ecSignatureDate>2025-05-26</ecSignatureDate>
  <duration>60</duration>
  <status>SIGNED</status>
  <keywords>Onchocerciasis, Persistent transmission, Loiasis, Co-endemicity, Moxidectin, Ivermectin, Phase IIIb community trial, Phase II safety trial, Acceptability, Elimination, Cameroon, Republic of Congo</keywords>
  <identifiers>
    <grantDoi>10.3030/101190878</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-06-01 01:14:49</sourceUpdateDate>
  <contentCreationDate>2025-06-03 10:12:45</contentCreationDate>
  <contentUpdateDate>2025-06-03 10:12:34</contentUpdateDate>
  <lastUpdateDate>2025-11-03 09:43:20</lastUpdateDate>
  <relations>
    <associations>
      <call source="corda" type="relatedMasterCall">
        <rcn>56830</rcn>
        <title>HORIZON-JU-GH-EDCTP3-2024-01-two-stage</title>
        <identifier>HORIZON-JU-GH-EDCTP3-2024-01-two-stage</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>56830</rcn>
        <title>HORIZON-JU-GH-EDCTP3-2024-01-two-stage</title>
        <identifier>HORIZON-JU-GH-EDCTP3-2024-01-two-stage</identifier>
      </call>
      <organization netEcContribution="419282.5" totalCost="419282.5" source="corda" order="5" ecContribution="419282.5" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1905566</rcn>
        <id>999993468</id>
        <vatNumber>GB649926678</vatNumber>
        <legalName>IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE</legalName>
        <address>
          <street>SOUTH KENSINGTON CAMPUS EXHIBITION ROAD</street>
          <city>London</city>
          <postalCode>SW7 2AZ</postalCode>
          <country>UK</country>
          <postBox>N/A</postBox>
          <url>http://www.imperial.ac.uk</url>
          <geolocation>51.5073219,-0.1276473</geolocation>
        </address>
        <departmentName>Faculty of Engineering, Level 2, Faculty Building</departmentName>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Westminster</name>
              <rcn>1465352</rcn>
              <nutsCode>UKI32</nutsCode>
              <parents>
                <region>
                  <name>Inner London — West</name>
                  <rcn>1465192</rcn>
                  <nutsCode>UKI3</nutsCode>
                  <parents>
                    <region>
                      <name>London</name>
                      <rcn>508635688</rcn>
                      <nutsCode>UKI</nutsCode>
                      <parents>
                        <region>
                          <name>United Kingdom</name>
                          <rcn>508725800</rcn>
                          <nutsCode>UK</nutsCode>
                          <euCode>UK</euCode>
                          <isoCode>GB</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>United Kingdom</name>
              <rcn>508725800</rcn>
              <nutsCode>UK</nutsCode>
              <euCode>UK</euCode>
              <isoCode>GB</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="2795847.5" totalCost="2795847.5" source="corda" order="2" ecContribution="2795847.5" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1992479</rcn>
        <id>911715417</id>
        <legalName>ASSOCIATION INSTITUT SUPERIEUR DE RECHERCHE SCIENTIFIQUE ET MEDICALES</legalName>
        <shortName>HIGHER INSTITUTE FOR SCIENTIFIC AND MEDICAL RESEARCH - ISM</shortName>
        <address>
          <street>285 STREET N 1.411 FOUDA QUARTER</street>
          <city>YAOUNDE 5</city>
          <postalCode>99</postalCode>
          <country>CM</country>
          <geolocation>2.73197,11.436763670503343</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Cameroon</name>
              <rcn>207260200</rcn>
              <nutsCode>CM</nutsCode>
              <euCode>CM</euCode>
              <isoCode>CM</isoCode>
            </region>
            <region type="relatedRegion">
              <name>Cameroon</name>
              <rcn>207260200</rcn>
              <nutsCode>CM</nutsCode>
              <euCode>CM</euCode>
              <isoCode>CM</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="948665" totalCost="948665" source="corda" order="3" ecContribution="948665" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1982566</rcn>
        <id>920133562</id>
        <vatNumber>GB336126223</vatNumber>
        <legalName>MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED</legalName>
        <address>
          <street>George Court, Bartholomew's Walk</street>
          <city>Ely</city>
          <postalCode>CB7 4JW</postalCode>
          <country>UK</country>
          <geolocation>52.2034823,0.1235817</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Cambridgeshire CC</name>
              <rcn>508629058</rcn>
              <nutsCode>UKH12</nutsCode>
              <parents>
                <region>
                  <name>East Anglia</name>
                  <rcn>508629096</rcn>
                  <nutsCode>UKH1</nutsCode>
                  <parents>
                    <region>
                      <name>East of England</name>
                      <rcn>508631592</rcn>
                      <nutsCode>UKH</nutsCode>
                      <parents>
                        <region>
                          <name>United Kingdom</name>
                          <rcn>508725800</rcn>
                          <nutsCode>UK</nutsCode>
                          <euCode>UK</euCode>
                          <isoCode>GB</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>United Kingdom</name>
              <rcn>508725800</rcn>
              <nutsCode>UK</nutsCode>
              <euCode>UK</euCode>
              <isoCode>GB</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="556250" totalCost="775969" source="corda" order="1" ecContribution="556250" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1905605</rcn>
        <id>999513803</id>
        <vatNumber>FR75180006025</vatNumber>
        <legalName>INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT</legalName>
        <shortName>IRD</shortName>
        <address>
          <street>BOULEVARD DE DUNKERQUE 44 CS 90009</street>
          <city>Marseille</city>
          <postalCode>13572</postalCode>
          <country>FR</country>
          <url>http://www.ird.fr</url>
          <geolocation>43.2961743,5.3699525</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Bouches-du-Rhône</name>
              <rcn>1464091</rcn>
              <nutsCode>FRL04</nutsCode>
              <parents>
                <region>
                  <name>Provence-Alpes-Côte d’Azur</name>
                  <rcn>1464968</rcn>
                  <nutsCode>FRL0</nutsCode>
                  <parents>
                    <region>
                      <name>Provence-Alpes-Côte d’Azur</name>
                      <rcn>1464967</rcn>
                      <nutsCode>FRL</nutsCode>
                      <parents>
                        <region>
                          <name>France</name>
                          <rcn>258902568</rcn>
                          <nutsCode>FR</nutsCode>
                          <euCode>FR</euCode>
                          <isoCode>FR</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>France</name>
              <rcn>258902568</rcn>
              <nutsCode>FR</nutsCode>
              <euCode>FR</euCode>
              <isoCode>FR</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="265966.25" totalCost="265966.25" source="corda" order="4" ecContribution="265966.25" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1967607</rcn>
        <id>892581488</id>
        <legalName>FONDATION CONGOLAISE POUR LA RECHERCHE MEDICALE</legalName>
        <address>
          <street>VILLA D6 CAMPUS WHO/AFRO DJOUE</street>
          <city>Brazzaville</city>
          <country>CG</country>
          <geolocation>-0.7264327,15.6419155</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/OTH</code>
              <title>Other</title>
              <displayCode>/Other</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Congo</name>
              <rcn>205687336</rcn>
              <nutsCode>CG</nutsCode>
              <euCode>CG</euCode>
              <isoCode>CG</isoCode>
            </region>
            <region type="relatedRegion">
              <name>Congo</name>
              <rcn>205687336</rcn>
              <nutsCode>CG</nutsCode>
              <euCode>CG</euCode>
              <isoCode>CG</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705741</rcn>
        <id>HORIZON.2.1</id>
        <code>HORIZON.2.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.2.1</pga>
        <title>Health</title>
        <parent>
          <programme>
            <rcn>705740</rcn>
            <code>HORIZON.2</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>708955</rcn>
        <id>HORIZON_HORIZON-JU-GH-EDCTP3-2024-01-03-two-stage</id>
        <code>HORIZON-JU-GH-EDCTP3-2024-01-03-two-stage</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>Accelerating development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450332</code>
              <title>Clinical research</title>
              <displayCode>/Clinical research</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456393</code>
              <title>Public health</title>
              <displayCode>/Public health</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43454992</code>
              <title>Neglected Infectious Diseases</title>
              <displayCode>/Neglected Infectious Diseases</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453510</code>
              <title>Infectious diseases</title>
              <displayCode>/Infectious diseases</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452784</code>
              <title>Global health</title>
              <displayCode>/Global health</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450338</code>
              <title>Clinical trials</title>
              <displayCode>/Clinical trials</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43455727</code>
              <title>Pharmaceutical development</title>
              <displayCode>/Pharmaceutical development</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/153/629</code>
        <title>epilepsy</title>
        <displayCode>/medical and health sciences/basic medicine/neurology/epilepsy</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="40">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="40">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-JU-RIA</code>
        <title>HORIZON JU Research and Innovation Actions</title>
        <description>HORIZON JU Research and Innovation Actions</description>
        <displayCode>/HORIZON JU Research and Innovation Actions</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>